Table 1.
MS patient demographic and clinical profile.
| mFIS | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sex | Age | DD | ARR | EDSS | BDI | Lesion load |
Pre Real |
Post Real |
% Real |
Pre Sham |
Post Sham |
% Sham |
|
| 14F, 4M | Ave/Med | 44.5 | 6.9 | 0 | 1.1 | 10.4 | 0.003 | 45.6 | 32.5 | 29.9 | 44.9 | 41.4 | 7.5 |
|
SD/ Ran |
10.4 | 5.5 | [0–2] | [0–3.5] | 3.1 | 0.002 | [31,66] | [9,55] | [2,76] | [30,67] | [26,69] | [−11,37] | |
F = female, M = male; mean (Ave) or median (Med, in italics) and SD = standard deviations or ranges (Ran) [min, max] across the 18 MS patients’ group of: DD = disease duration; ARR = annual relapse rate; Scores of: EDSS = Expanded Disability Status Scale, BDI = Beck Depression Inventory; Lesion load: volume of the lesion divided by the intra-cranial volume, as assessed by NeuroQuant algoritms (CorTechs Labs, Inc. San Diego, CA, USA); mFIS = modified fatigue impact scale; Pre and Post FaReMuS and the percentage change with respect to baseline (%, defined as (pre-post)/pre) for Real and Sham stimulations.